MOTS-c MS40 40mg*10vials

MOTS-c MS40 40mg*10 vials is the ultra-premium specification in the MOTS-c mitochondrial metabolic peptide series, a super-efficient ultimate upgrade surpassing the flagship versions MS10, MS15, and MS20. As a highly active endogenous mitochondrial-encoded short-chain peptide, it exhibits zero immunogenicity and excellent biocompatibility, inheriting the unique exercise-mimicking metabolic activation mechanism of the MOTS-c series while breaking through the traditional 20mg maximum dose saturation threshold. The industry-leading 40mg ultra-saturated dose achieves supersaturated activation of the AMPK energy pathway and complete ultra-high-load inhibition of mTOR pathological signals, thereby releasing unprecedented extreme metabolic remodeling, comprehensive reversal of mitochondrial damage, and deep-seated systemic anti-aging effects. Specifically tailored for modeling and end-stage research of extremely severe refractory metabolic disorders, it is a core, top-tier preclinical research material for cutting-edge research in extreme mitochondrial physiology, severe metabolic pharmacology, and advanced degenerative aging.

Product Functions and Research Value

In ultra-high-intensity, extreme systemic laboratory studies, MOTS-c MS40 40mg can trigger the activation of supersaturated AMPK energy cascades, maximize comprehensive mTOR pathological inhibition, and achieve comprehensive, ultra-deep mitochondrial biosynthetic reconstruction, thereby achieving ultimate physiological metabolic recovery and systemic anti-aging reset that conventional saturation formulations cannot reach. Its core ultra-extreme research advantages cover five major areas: ultra-amplitude metabolic bursts mimicking exercise, completely reversing stubborn metabolic inertia; peak insulin sensitivity enhancement, fundamentally correcting stubborn glucose metabolism disorders; comprehensive and deep breakdown of stubborn visceral, liver, and systemic lipid accumulation; ultra-thorough elimination of severe mitochondrial oxidative stress and stubborn chronic inflammation; and comprehensive ultra-deep elimination of senescent cells, blocking the degenerative aging process of multiple organs. The efficacy of MS40 40mg far exceeds the saturation level of the flagship MS20, possessing ultra-high amplitude instantaneous extreme experimental phenotypes, long-term zero-attenuation ultra-strong efficacy output, and the ability to reset physiological homeostasis across multiple organs under full load. It uniquely intervenes in severe refractory metabolic syndrome, end-stage mitochondrial dysfunction, advanced deep tissue aging, and refractory low-grade inflammation accumulation insensitive to conventional high-dose regimens. It can completely reverse metabolic failure caused by an extremely high-fat diet, thoroughly clear stubborn lipid deposits in the liver, visceral cavities, and peripheral tissues, and maximize systemic energy circulation efficiency and exercise physiological potential. Simultaneously, it achieves comprehensive repair of mitochondrial function in multiple organs, completely eliminates lifelong accumulated oxidative free radicals, eradicates persistent and refractory chronic inflammation, and exerts outstanding multi-organ protection and ultra-deep anti-aging effects. The 40mg ultra-limit, supersaturated upper limit specification perfectly matches ultra-limit dose threshold screening, end-stage severe metabolic damage modeling, advanced multi-organ degenerative aging intervention, and ultra-high standard complex peptide synergistic effect limit verification, providing authoritative and reproducible data with ultra-high discrimination for cutting-edge mitochondrial metabolic anti-aging research.

Core Product Advantages

1. **Ultra-Saturated Mitochondrial Pathway Activation:** The industry-leading 40mg ultra-high dose achieves explosive activation of the AMPK pathway through supersaturation, far exceeding the saturation limit of traditional flagship formulations. This maximizes mitochondrial biosynthesis and ultra-efficient energy conversion, reaching the upper limit of mitochondrial metabolic activation in the MOTS-c series.

2. **Thorough and Powerful Correction of Metabolic Disasters:** Possesses extremely high-intensity glucose and lipid remodeling and insulin resistance reversal capabilities, completely correcting end-stage refractory severe metabolic disorders that are insensitive to MS20 saturation doses. This represents the pinnacle of MOTS-c peptide metabolic regulatory efficacy.

3. **Five-Dimensional Super-Powerful System Physiological Reset:** Integrates ultra-explosive exercise-simulated fat burning, thorough correction of refractory hyperglycemia, systemic refractory lipid clearance, and ultra-thorough mitochondrial oxygenation.